Fas Secured Creditors Holdco, LLC
Records under this name other than the patents Fas Secured Creditors Holdco, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Fas Secured Creditors Holdco, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,649,012 | Pharmaceutical Compositions Containing Same, and Methods of Use for Same Lapsed on the fee record Ended Jan 19, 2018 · High confidence | Lapsed on the fee record | Ended Jan 19, 2018 | High confidence |
| US 7,459,481 | Stimulation of CPT-1 as a Means to Reduce Weight Lapsed on the fee record Ended Dec 2, 2016 · High confidence | Lapsed on the fee record | Ended Dec 2, 2016 | High confidence |
| US 8,293,791 | Novel Method of Neuroprotection by Pharmacological Inhibition of Amp-Activated Protein Kinase Lapsed on the fee record Ended Oct 23, 2016 · High confidence | Lapsed on the fee record | Ended Oct 23, 2016 | High confidence |
| US 8,247,188 | FAS binding antibodies Lapsed on the fee record Ended Aug 21, 2016 · USPTO record | Lapsed on the fee record | Ended Aug 21, 2016 | USPTO record |
| US 7,385,086 | Antimicrobial Compounds Lapsed on the fee record Ended Jun 10, 2012 · Medium confidence | Lapsed on the fee record | Ended Jun 10, 2012 | Medium confidence |
| US 6,713,654 | Antimicrobial compounds Lapsed on the fee record Ended Mar 30, 2012 · USPTO record | Lapsed on the fee record | Ended Mar 30, 2012 | USPTO record |
| US 5,614,551 | Inhibitors of fatty acid synthesis as antimicrobial agents Term ended Term ended no later than Mar 25, 2017 · Low confidence | Term ended | Term ended no later than Mar 25, 2017 | Low confidence |
| US 5,665,874 | Cancer related antigen Term ended Term ended no later than Sep 9, 2017 · Low confidence | Term ended | Term ended no later than Sep 9, 2017 | Low confidence |
| US 5,759,791 | Cancer related antigen Term ended Term ended no later than Jun 2, 2018 · Low confidence | Term ended | Term ended no later than Jun 2, 2018 | Low confidence |
| US 5,759,837 | Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway Term ended Term ended no later than Jun 2, 2018 · Low confidence | Term ended | Term ended no later than Jun 2, 2018 | Low confidence |